Current Report Filing (8-k)
November 20 2020 - 2:46PM
Edgar (US Regulatory)
false
0001385280
0001385280
2020-11-20
2020-11-20
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): November 20, 2020
Cinemark Holdings, Inc.
(Exact Name of Registrant as Specified in Charter)
|
|
|
|
|
Delaware
|
|
001-33401
|
|
20-5490327
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
3900 Dallas Parkway, Plano, Texas 75093
(Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code: 972.665.1000
N/A
(Former Name or Former Address, if Changed Since Last Report)
|
|
|
|
|
Title of each class
|
|
Trading
Symbol(s)
|
|
Name of each exchange
on which registered
|
Common Stock
|
|
CNK
|
|
NYSE
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01
|
Entry into a Material Definitive Agreement.
|
Effective November 18, 2020 (the “Effective Date”), Cinemark Holdings, Inc. (the “Company”) entered into the Second Amended and Restated Employment Agreement with Mark Zoradi (the “Restated Employment Agreement”). The Restated Employment Agreement extends the term of Mr. Zoradi’s employment from December 31, 2020 to December 31, 2021 (the “Term”), provided however, the end of the Term may be accelerated upon the mutual agreement of Mr. Zoradi and the Board of Directors of the Company (the “Board”). Additionally, upon termination of Mr. Zoradi’s employment by us without cause or his resignation for good reason, Mr. Zoradi and his dependents shall be entitled to continue to participate in the Company's group health insurance programs on the same terms as similarly situated active employees for a period of 18 months instead of 24 months as was previously provided.
The foregoing description is qualified in its entirety by reference to the full text of the Restated Employment Agreement, which is attached hereto as Exhibit 10.1 and incorporated by reference herein.
Item 5.02
|
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
Effective November 19, 2020, the Board approved an amendment and restatement of the Cinemark Holdings, Inc. 2017 Omnibus Incentive (the “Restated Omnibus Plan”) amending the Cinemark Holdings, Inc. 2017 Omnibus Plan (the “Omnibus Plan”). The Omnibus Plan, approved by the Company’s stockholders at the 2017 annual meeting, was amended to delete certain provisions, including defined terms and timing requirements, that are no longer applicable due to the elimination of the performance-based compensation exception to Section 162(m) of the Internal Revenue Code.
The foregoing description of the Restated Omnibus Plan is qualified in its entirety by reference to the full text of the Restated Omnibus Plan, which is attached hereto as Exhibit 10.2 and incorporated by reference herein.
Item 9.01
|
Financial Statements and Exhibits.
|
(d)Exhibits.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
CINEMARK HOLDINGS, INC.
|
|
|
By:
|
|
/s/ Michael D. Cavalier
|
Name:
|
|
Michael D. Cavalier
|
Title:
|
|
Executive Vice President - General Counsel
|
Date: November 20, 2020
Cinemark (NYSE:CNK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cinemark (NYSE:CNK)
Historical Stock Chart
From Apr 2023 to Apr 2024